IndiaCOVID-19Ministry of Health and Family WelfareHealth

COVID – 19 Vaccination Update – Day 412

India’s cumulative vaccination coverage crosses 178.26 Crore. More than 21 lakh Vaccine doses administered today till 7 pm

India’s COVID-19 vaccination coverage has crossed 178.26 Crore (1,78,26,22,997) today. More than 21 lakh (21,99,122Vaccine Doses have been administered till 7 pm today. More than 2.03 Crore (2,03,60,743) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10401847
2nd Dose 9971610
Precaution Dose 4213377
FLWs 1st Dose 18410002
2nd Dose 17451499
Precaution Dose 6308952
Age Group 15-18 years 1st Dose 55135531
  2nd Dose 29382524
Age Group 18-44 years 1st Dose 552207455
2nd Dose 447099631
Age Group 45-59 years 1st Dose 202337506
2nd Dose 180800738
Over 60 years 1st Dose 126464601
2nd Dose 112599310
Precaution Dose 9838414
Cumulative 1st dose administered 964956942
Cumulative 2nd dose administered 797305312
Precaution Dose 20360743
Total 1782622997

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 3rd March, 2022 (412th Day)
HCWs 1st Dose 77
2nd Dose 1490
Precaution Dose 12980
FLWs 1st Dose 112
2nd Dose 2615
Precaution Dose 17796
Age Group 15-18 years 1st Dose 103018
  2nd Dose 612002
Age Group 18-44 years 1st Dose 124157
2nd Dose 899767
Age Group 45-59 years 1st Dose 19091
2nd Dose 198834
Over 60 years 1st Dose 15790
2nd Dose 120838
Precaution Dose 70555
Cumulative 1st dose administered 262245
Cumulative 2nd dose administered 1835546
Precaution Dose 101331
Total 2199122

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker